News and updates — Page 2 of 23 — German Market Access

G-BA decisions from 4 July 2024

Here are the G-BA decisions from the G-BA meeting held on 4 July 2024 on the early benefit assessments of Agamree, Loargys,

In April 2024, I wrote a guest post for Market Access Today. Introduction Entering the dynamic realm of pharmaceutical pricing in Germany,

Are confidential drug prices coming to Germany? Until now, the reimbursed prices of drugs are in the public domain (Lauer Taxe), but

Here are the G-BA decisions from the G-BA meeting held on 20 June 2024 on the early benefit assessments of Jemperli, Ayvakyt,

Here are the G-BA decisions from the G-BA meeting held on 6 June 2024 on the early benefit assessments of Prevymis, Ebglyss,